{
    "nct_id": "NCT03310918",
    "official_title": "Randomized Trial of a Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy",
    "inclusion_criteria": "* Patients with AML receiving non-intensive therapy including hypomethylating agents, single-agent chemotherapy, targeted therapy agents, or single or combination non-intensive agents offered on a clinical trial, including the following populations:\n\n  * Newly diagnosed AML\n  * Relapsed AML\n  * Primary refractory AML\n* The ability to provide informed consent\n* The ability to comprehend English or complete questionnaires with minimal assistance of an interpreter\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients not receiving care at MGH\n* Patients receiving intensive chemotherapy (requiring 4-6 week hospitalization)\n* Patients receiving supportive care alone\n* Major psychiatric illness or co-morbid conditions prohibiting compliance with study procedures\n* Patients already receiving palliative care",
    "miscellaneous_criteria": ""
}